Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA Expression and Clinical Outcome of Small Cell Lung Cancer

22 Jun 2011

Abstract excerpt

The role of microRNAs in small-cell lung carcinoma (SCLC) is largely unknown. miR-34a is known as a p53 regulated tumor suppressor microRNA in many cancer types. However, its therapeutic implication has never been studied in SCLC, a cancer type with frequent dysfunction of p53. We investigated the expression of a panel of 7 microRNAs (miR-21, miR-29b, miR-34a/b/c, miR-155, and let-7a) in 31 SCLC tumors, 14 SCLC...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Mechanisms and Therapy
Share to Circular RNAs in diseases
Share to MicroRNA in disease regulation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 21731696
DOI: 10.1371/journal.pone.0021300

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 9 closest

MicroRNA Expression and Clinical Outcome of Small Cell Lung CancerPMID 21731696Read ↗

MicroRNA expression and clinical outcomes in patients treated with adjuvant chemotherapy after complete resection of non-small cell lung carcinoma.Semantic proximity Read ↗

MicroRNA expression distinguishes SCLC from NSCLC lung tumor cells and suggests a possible pathological relationship between SCLCs and NSCLCsSemantic proximity Read ↗

The microRNA expression signature of small cell lung cancer: tumor suppressors of miR-27a-5p and miR-34b-3p and their targeted oncogenesSemantic proximity Read ↗

Let-7g and miR-21 expression in non-small cell lung cancer: correlation with clinicopathological and molecular features.Semantic proximity Read ↗

Survivin expression impacts prognostically on NSCLC but not SCLC.Semantic proximity Read ↗

MicroRNA‐30a inhibits epithelial‐to‐mesenchymal transition by targeting Snai1 and is downregulated in non‐small cell lung cancerSemantic proximity Read ↗

microRNA-34a sensitizes lung cancer cell lines to DDP treatment independent of p53 status.Semantic proximity Read ↗

Prognostic significance of mutant p53 protein, P-glycoprotein and glutathione S-transferase-pi in patients with unresectable non-small cell lung cancer.Semantic proximity Read ↗

Serum CD44 levels in patients with non-small cell lung cancer and their relationship with clinicopathological features.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.